Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block Listing Return

4 Jan 2021 14:09

RNS Number : 4792K
Oxford Biomedica PLC
04 January 2021
 

For Immediate Release

04 January 2021

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

173,014

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

200,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

159,816

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

213,198

     

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

211,739

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

31,979

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

179,760

     

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

85,644

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

100,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

29,965

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

155,679

     

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

292,180

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

51,829

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

240,351

     

 

Name of contact:

Natalie Walter

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBIMITMTMMBIB
Date   Source Headline
15th Aug 20147:00 amRNSPaul Blake Appointed as Chief Development Officer
7th Aug 20147:00 amRNSNotice of Results
25th Jul 20149:48 amRNSBlock listing Application
1st Jul 201410:55 amRNSOxford BioMedica plc Director's Share Purchase
30th Jun 20147:00 amRNSTotal Voting Rights Update
23rd Jun 20147:00 amRNSDirectors' Interest in Share Options
20th Jun 20142:38 pmRNSPiper Jaffray GenomeRx Symposium in New York
19th Jun 20149:50 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:01 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:00 amRNSGRANT OF AWARDS
18th Jun 201411:30 amRNSLoan Repayment in Full
18th Jun 20149:36 amRNSHolding(s) in Company
18th Jun 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jun 201412:29 pmRNSRESULT OF GENERAL MEETING AND DIRECTORS DEALING
16th Jun 20147:00 amRNSResults of firm fundraising and open offer
3rd Jun 201412:34 pmRNSResult of AGM
29th May 20144:52 pmRNSNotice of posting of prospectus
29th May 20147:00 amRNSFundraising and Open Offer
22nd May 20149:22 amRNSDirector Declaration
13th May 20147:00 amRNSInterim Management Statement
2nd May 20144:57 pmRNS2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30th Apr 20147:00 amRNS£2.2 Million Grant Received from TSB
29th Apr 20147:00 amRNSOxford BioMedica provides update on RetinoStat®
10th Apr 20147:00 amRNSFinal Results
7th Apr 20147:00 amRNSOXB completes patient recruitment into RetinoStat
21st Mar 20147:00 amRNSOXB Present at Regen Med Investor Day
17th Feb 20147:00 amRNSOxford BioMedica and Sanofi Amend Terms for Ocular
17th Jan 20144:40 pmRNSSecond Price Monitoring Extn
17th Jan 20144:35 pmRNSPrice Monitoring Extension
10th Jan 20147:00 amRNSPublication of ProSavin Phase I/II Study
9th Jan 201412:19 pmRNSOxford BioMedica to Present at Biotech Showcase
6th Jan 201410:28 amRNSOxford Biomedica PLC - General Meeting
18th Dec 20137:00 amRNSOXB option agreement with GSK
11th Dec 20137:00 amRNSCIRCULAR & GENERAL MEETING NOTIFICATION
22nd Nov 201312:38 pmRNSDirector/PDMR Shareholding
19th Nov 20137:00 amRNS£5 million Loan Facility from Lead Shareholder
19th Nov 20137:00 amRNSInterim Management Statement
17th Oct 20137:00 amRNSAgreement to Resume Clinical Trials
19th Sep 20137:00 amRNSDirector/PDMR Shareholding
17th Sep 20131:06 pmRNSBlock Listing Return
12th Sep 201311:18 amRNSOxford BioMedica plc Director's Share Purchase
11th Sep 20131:01 pmRNSOxford BioMedica Wins Significant Funding
6th Sep 20134:40 pmRNSSecond Price Monitoring Extn
6th Sep 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20134:08 pmRNSTR1 Form
29th Aug 20137:00 amRNSInterim Results 2013
28th Aug 20137:00 amRNSUS$1 million Milestone Payment from Pfizer
14th Aug 20131:00 pmRNSAnnounced as Funding Competition Winner
29th Jul 20137:00 amRNSPublication of TroVax Phase II Analyses
23rd Jul 20137:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.